Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers

[1]  V. Kuznetsov,et al.  Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers , 2015, BMC Genomics.

[2]  Yixue Li,et al.  Big Biological Data: Challenges and Opportunities , 2014, Genom. Proteom. Bioinform..

[3]  J. Vadgama,et al.  IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion , 2014, PloS one.

[4]  H. Gabra,et al.  Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures , 2014, Modern Pathology.

[5]  Vladimir A Kuznetsov,et al.  Meta‐analysis of transcriptome reveals let‐7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high‐grade serous ovarian carcinoma , 2014, International journal of cancer.

[6]  Luonan Chen,et al.  Computational systems biology in the big data era , 2013, BMC Systems Biology.

[7]  Ling-Zhi Wang,et al.  Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer , 2013, EMBO molecular medicine.

[8]  Ghim Siang Ow,et al.  How to discriminate between potentially novel and considered biomarkers within molecular signature? , 2013, 2013 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB).

[9]  Cesare Furlanello,et al.  Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review , 2012, PloS one.

[10]  Geng-yin Zhou,et al.  Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway. , 2012, Cancer letters.

[11]  N. Simone,et al.  Weight Gain, Metabolic Syndrome, and Breast Cancer Recurrence: Are Dietary Recommendations Supported by the Data? , 2012, International journal of breast cancer.

[12]  Benjamin Haibe-Kains,et al.  Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer , 2012, PloS one.

[13]  Aedín C. Culhane,et al.  GeneSigDB: a manually curated database and resource for analysis of gene expression signatures , 2011, Nucleic Acids Res..

[14]  Cesare Furlanello,et al.  Algebraic Comparison of Partial Lists in Bioinformatics , 2010, PloS one.

[15]  B. Damavandi.  Estimating the Overlap of Top Instances in Lists Ranked by Correlation to Label , 2012 .

[16]  C. Creighton,et al.  A gene transcription signature of obesity in breast cancer , 2012, Breast Cancer Research and Treatment.

[17]  V. Kuznetsov,et al.  A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma , 2011, BMC Genomics.

[18]  P. Lizardi,et al.  Genome-wide approaches for cancer gene discovery. , 2011, Trends in biotechnology.

[19]  J. Reseland,et al.  Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis. , 2011, Gynecologic oncology.

[20]  Igor Jurisica,et al.  Integrative computational biology for cancer research , 2011, Human Genetics.

[21]  L. Chin,et al.  Making sense of cancer genomic data. , 2011, Genes & development.

[22]  Jung-Hsien Chiang,et al.  Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies. , 2010, Gynecologic oncology.

[23]  Vladimir A Kuznetsov,et al.  Statistics of protein-DNA binding and the total number of binding sites for a transcription factor in the mammalian genome , 2010, BMC Genomics.

[24]  M. Abba,et al.  Breast Cancer Biomarker Discovery in the Functional Genomic Age: A Systematic Review of 42 Gene Expression Signatures , 2010, Biomarker insights.

[25]  J. Beckmann,et al.  The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway , 2009, Oncogene.

[26]  C. Oshima,et al.  Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer. , 2009, Oncology reports.

[27]  Holger Sültmann,et al.  Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. , 2009, Lung cancer.

[28]  V. Kuznetsov,et al.  Data-driven approach to predict survival of cancer patients , 2009, IEEE Engineering in Medicine and Biology Magazine.

[29]  Adrian V. Lee,et al.  Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Wong,et al.  HGF/MET signaling in ovarian cancer. , 2008, Current molecular medicine.

[31]  E. Gehan,et al.  The properties of high-dimensional data spaces: implications for exploring gene and protein expression data , 2008, Nature Reviews Cancer.

[32]  Bilge Karaçali,et al.  Prediction potential of candidate biomarker sets identified and validated on gene expression data from multiple datasets , 2007, BMC Bioinformatics.

[33]  A. Mes-Masson,et al.  Comparative proteome analysis of human epithelial ovarian cancer , 2007, Proteome Science.

[34]  Léon Personnaz,et al.  Enrichment or depletion of a GO category within a class of genes: which test? , 2007, Bioinform..

[35]  Vladimir A. Kuznetsov,et al.  Pareto-Gamma Statistic Reveals Global Rescaling in Transcriptomes of Low and High Aggressive Breast Cancer Phenotypes , 2006, PRIB.

[36]  Maurice P H M Jansen,et al.  Molecular profiling of platinum resistant ovarian cancer , 2006, International journal of cancer.

[37]  L. Ein-Dor,et al.  Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[40]  Dennis B. Troup,et al.  NCBI GEO: mining millions of expression profiles—database and tools , 2004, Nucleic Acids Res..

[41]  Sergio Contrino,et al.  ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..

[42]  Luigi Marchionni,et al.  Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 , 2004, Oncogene.

[43]  V. Kuznetsov.  Statistics of the Numbers of Transcripts and Protein Sequences Encoded in the Genome , 2003 .

[44]  I. Shmulevich,et al.  Computational and Statistical Approaches to Genomics , 2007, Springer US.

[45]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[46]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[47]  David E. Hapeman.  Statistical Analysis of Categorical Data , 1999, Technometrics.

[48]  R. Brand,et al.  Elevated insulin receptor content in human breast cancer. , 1990, The Journal of clinical investigation.

[49]  E. B. Andersen,et al.  The Statistical Analysis of Categorical Data , 1990 .